Caprock Group LLC bought a new stake in Globe Life Inc. (NYSE:GL - Free Report) in the fourth quarter, according to its most recent filing with the Securities & Exchange Commission. The firm bought 4,631 shares of the company's stock, valued at approximately $517,000.
A number of other hedge funds and other institutional investors have also recently bought and sold shares of the stock. DMC Group LLC lifted its holdings in Globe Life by 45.1% during the 4th quarter. DMC Group LLC now owns 3,194 shares of the company's stock worth $356,000 after buying an additional 993 shares during the last quarter. Swedbank AB purchased a new stake in Globe Life during the 4th quarter worth about $52,414,000. Hantz Financial Services Inc. lifted its holdings in Globe Life by 12.8% during the 4th quarter. Hantz Financial Services Inc. now owns 13,594 shares of the company's stock worth $1,516,000 after buying an additional 1,546 shares during the last quarter. Robeco Institutional Asset Management B.V. lifted its holdings in Globe Life by 396.7% during the 4th quarter. Robeco Institutional Asset Management B.V. now owns 15,025 shares of the company's stock worth $1,676,000 after buying an additional 12,000 shares during the last quarter. Finally, Pacer Advisors Inc. lifted its holdings in Globe Life by 56.0% during the 4th quarter. Pacer Advisors Inc. now owns 10,199 shares of the company's stock worth $1,137,000 after buying an additional 3,662 shares during the last quarter. 81.61% of the stock is currently owned by hedge funds and other institutional investors.
Wall Street Analyst Weigh In
GL has been the subject of a number of recent analyst reports. Raymond James lifted their price target on Globe Life from $160.00 to $188.00 and gave the stock a "strong-buy" rating in a report on Tuesday, October 15th. Keefe, Bruyette & Woods lifted their target price on Globe Life from $135.00 to $137.00 and gave the stock an "outperform" rating in a research report on Friday, January 10th. Evercore ISI upgraded Globe Life from an "in-line" rating to an "outperform" rating and lifted their target price for the stock from $132.00 to $143.00 in a research report on Wednesday, January 8th. Morgan Stanley lifted their target price on Globe Life from $110.00 to $120.00 and gave the stock an "equal weight" rating in a research report on Thursday, October 24th. Finally, Truist Financial lifted their target price on Globe Life from $90.00 to $105.00 and gave the stock a "hold" rating in a research report on Friday, October 25th. Five equities research analysts have rated the stock with a hold rating, six have assigned a buy rating and one has given a strong buy rating to the company. Based on data from MarketBeat, the stock has an average rating of "Moderate Buy" and an average price target of $132.18.
Check Out Our Latest Stock Report on Globe Life
Globe Life Stock Performance
GL stock traded up $3.66 during trading on Friday, hitting $123.63. The company had a trading volume of 958,110 shares, compared to its average volume of 510,240. The firm has a market cap of $10.38 billion, a PE ratio of 10.35 and a beta of 0.81. Globe Life Inc. has a 1-year low of $38.95 and a 1-year high of $132.00. The firm has a 50-day moving average price of $113.19 and a 200-day moving average price of $106.99. The company has a quick ratio of 0.05, a current ratio of 0.05 and a debt-to-equity ratio of 0.50.
Globe Life (NYSE:GL - Get Free Report) last issued its quarterly earnings results on Wednesday, February 5th. The company reported $3.14 earnings per share (EPS) for the quarter, beating the consensus estimate of $3.12 by $0.02. Globe Life had a return on equity of 22.32% and a net margin of 18.53%. On average, analysts expect that Globe Life Inc. will post 13.57 earnings per share for the current year.
Globe Life Announces Dividend
The firm also recently announced a quarterly dividend, which was paid on Friday, January 31st. Shareholders of record on Monday, January 6th were given a dividend of $0.24 per share. This represents a $0.96 annualized dividend and a yield of 0.78%. The ex-dividend date of this dividend was Monday, January 6th. Globe Life's payout ratio is 8.03%.
Insiders Place Their Bets
In other news, Director Mark A. Blinn sold 3,000 shares of the business's stock in a transaction that occurred on Monday, January 6th. The stock was sold at an average price of $113.23, for a total transaction of $339,690.00. Following the sale, the director now owns 5,122 shares of the company's stock, valued at $579,964.06. The trade was a 36.94 % decrease in their position. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available through this hyperlink. Also, CEO Frank M. Svoboda sold 14,340 shares of the business's stock in a transaction that occurred on Tuesday, December 3rd. The stock was sold at an average price of $108.80, for a total value of $1,560,192.00. Following the sale, the chief executive officer now directly owns 16,396 shares in the company, valued at $1,783,884.80. This trade represents a 46.66 % decrease in their position. The disclosure for this sale can be found here. In the last 90 days, insiders have sold 39,788 shares of company stock worth $4,429,779. Company insiders own 1.51% of the company's stock.
About Globe Life
(
Free Report)
Globe Life Inc, through its subsidiaries, provides various life and supplemental health insurance products, and annuities to lower middle- and middle-income families in the United States. The company operates in four segments: Life Insurance, Supplemental Health Insurance, Annuities, and Investments.
Featured Articles

Before you consider Globe Life, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Globe Life wasn't on the list.
While Globe Life currently has a "Moderate Buy" rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
MarketBeat has just released its list of 20 stocks that Wall Street analysts hate. These companies may appear to have good fundamentals, but top analysts smell something seriously rotten. Are any of these companies lurking around your portfolio?
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.